Clinical trial
SIMPADICO - Study of Immune Modulation Therapy in Peripheral Arterial Disease…
NCT00111826 · Vasogen, Industry · Terminated
Key facts
| NCT number | NCT00111826 |
|---|---|
| Title | SIMPADICO - Study of Immune Modulation Therapy in Peripheral Arterial Disease and Intermittent Claudication Outcomes |
| Official title | Multi-Center, Randomized, Double-Blind, Placebo-Controlled Study of Efficacy and Safety of the Celacade™ System in Improving Walking Distance in Patients With Intermittent Claudication Secondary to Peripheral Arterial Disease |
| Lead sponsor | Vasogen, Industry |
| Status | Terminated |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Peripheral Arterial Disease, Arterial Occlusive Diseases, Intermittent Claudication |
| Intervention type | Device |
| Interventions | Celacade™ system |
| Enrollment | 500 |
| Start date | Jan 1, 2003 |
| Completion | Dec 1, 2005 |
| First posted | May 26, 2005 |
| Last update posted | Mar 31, 2010 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: